What does CUSIP 71880W303 represent in this 13F holders report?

CUSIP 71880W303 is the security identifier for PHIO - PHIO PHARMACEUTICALS CORP - COM NEW used to aggregate holder disclosures.

How many institutions held PHIO - PHIO PHARMACEUTICALS CORP - COM NEW in Q3 2022?

12 institutional investors reported PHIO - PHIO PHARMACEUTICALS CORP - COM NEW for Q3 2022. Use the holders table for investor-level position and value details.

PHIO PHARMACEUTICALS CORP - COM NEW (PHIO)

CUSIP: 71880W303

Q3 2022 13F Holders as of 30 Sep 2022

Security type / class: Equity / COM NEW
Total 13F shares: 726,714
Total 13F value: $415,000
Share change: -52,322
SEC-reported price per share: $0.57
Number of holders: 12
Value change: -$30,600
Number of buys: 5
Number of sells: 5

Security key

71880W303

Report period

Q3 2022

Institutions

Top holders

PHIO full security history Ownership snapshot Full 13F holder table Phio Pharmaceuticals Corp. SEC filings Phio Pharmaceuticals Corp. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of PHIO - PHIO PHARMACEUTICALS CORP - COM NEW (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Gerrit Dispersyn

Disclosed value leader

Gerrit Dispersyn

Comparable rows

0/12

Latest evidence

30 Jun 2022

3/4/5 13F Highest disclosed value: $320,614 12 rows are not safely comparable across share classes. Showing 1-6 of 12 holder rows.

Quick read

Gerrit Dispersyn has the largest disclosed position value at $320.6K.

0 of 12 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Gerrit Dispersyn's linked filing trail.

Disclosed position value Top 5

Gerrit Dispersyn $320.6K

VANGUARD GROUP INC $210K

RENAISSANCE TECHNOLOGIES LLC $165K

GEODE CAPITAL MANAGEMENT, LLC $77K

Cetera Investment Advisers $53K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 12 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Gerrit Dispersyn	3/4/5 President & CEO, Director 3/4/5	— denominator unverified	$320,614 212,327 shares	—	01 Mar 2022
VANGUARD GROUP INC	13F Company 13F	— denominator unverified	$210,000 297,971 shares	—	30 Jun 2022
RENAISSANCE TECHNOLOGIES LLC	13F Company 13F	— denominator unverified	$165,000 234,849 shares	—	30 Jun 2022
GEODE CAPITAL MANAGEMENT, LLC	13F Company 13F	— denominator unverified	$77,000 107,192 shares	—	30 Jun 2022
Cetera Investment Advisers	13F Company 13F	— denominator unverified	$53,000 75,000 shares	—	30 Jun 2022
H. Paul Dorman	3/4/5 Director 3/4/5	— denominator unverified	$30,759 20,370 shares	—	15 Feb 2022

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

726,714

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2022 vs Q2 2022 Across Filers

Q2 2022 holders

Q3 2022 holders

Holder diff

Investor	Q2 2022 Shares	Q3 2022 Shares	Share Diff	Share Chg %	Q2 2022 value	Q3 2022 value	Value change	Value Chg %